United States · 
Who invested in Alterome Therapeutics?
Alterome Therapeutics's investors include Goldman Sachs, Canaan, OrbiMed, Digitalis Ventures and Blue Owl.
United States · Series B startup
Who invested in Alterome Therapeutics
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$132Mraised across 1 round since 2024, from 1 source
- Latest round
- Series B, $132MApr 2024
- Investors
- 5
The rounds
- Apr 2024
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Alterome Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Alterome Therapeutics
How much has Alterome Therapeutics raised?
Alterome Therapeutics has raised $132M across 1 round since 2024.
When did Alterome Therapeutics last raise?
Alterome Therapeutics's most recent round was a Series B of $132M in Apr 2024.
What was Alterome Therapeutics's biggest round?
Its most recent round, $132M in Apr 2024, is also its largest on record.
Who backed Alterome Therapeutics first?
Alterome Therapeutics's first round on record, in Apr 2024, was backed by Goldman Sachs, Canaan and OrbiMed and 2 others.
What stage is Alterome Therapeutics at?
Alterome Therapeutics's latest named round is a Series B, in Apr 2024.
Where is Alterome Therapeutics based?
Alterome Therapeutics is based in the United States.
Companies like Alterome Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.